Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expression of anthrax lethal factor gene by osmolyte induction.

Aparna Singh1, Samer Singh, Syed Mohsin Waheed

  • 1Centre for Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.

FEMS Microbiology Letters
|May 15, 2002
PubMed
Summary

Researchers developed a novel osmolyte-inducible system for expressing lethal factor (LF), a key component in anthrax toxin vaccines. This system produces pure LF, suitable for human vaccine trials and enhancing protective immunity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated adsorption-ozonation process using activated canna indica biochar for enhanced COD and color removal from real textile effluent.

Scientific reports·2026
Same author

Metabolotheranostics of pancreatic cancer by targeting choline, glutamine, and glucose transporters with photoimmunotherapy.

Npj imaging·2026
Same author

Genetic characterization of tigecycline and carbapenem resistant Acinetobacter baumannii in a tertiary care hospital of Northern India.

BMC microbiology·2026
Same author

Epidemiology of Human and Animal Anthrax in India, 1990-2022: A Comprehensive Analysis of Literature and National Surveillance Data.

BioMed research international·2025
Same author

Clinically Relevant Findings in Lung Cancer Staging.

Radiographics : a review publication of the Radiological Society of North America, Inc·2025
Same author

Real-world effectiveness and safety of hyperthermic intraperitoneal chemotherapy and intraperitoneal chemotherapy in ovarian cancer.

The oncologist·2025

Area of Science:

  • Biochemistry
  • Immunology
  • Vaccine Development

Background:

  • Anthrax toxin comprises protective antigen (PA), lethal factor (LF), and edema factor (EF).
  • PA facilitates the cellular entry of LF and EF.
  • While PA is the primary vaccine antigen, LF also boosts immunity.

Purpose of the Study:

  • To develop an osmolyte-inducible expression system for recombinant lethal factor (LF).
  • To produce LF suitable for human vaccine trials by avoiding additional amino acids.

Main Methods:

  • Development of an osmolyte-inducible protein expression system.
  • Production of recombinant LF using the developed system.

Main Results:

  • The expression system successfully produced recombinant LF.

Related Experiment Videos

  • The recombinant LF contained no extraneous amino acids, ensuring purity.
  • The system is suitable for producing LF for human vaccine applications.

    • Conclusions:

    • An osmolyte-inducible LF expression system has been successfully developed.
    • This system yields pure recombinant LF, ideal for anthrax vaccine development.
    • The system supports the advancement of LF-based vaccine strategies.